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Development of an optogenetically controllable human neural network model in
three‐dimensional (3D) cultures can provide an investigative system that is more
physiologically relevant and better able to mimic aspects of human brain function.
Light‐sensitive neurons were generated by transducing channelrhodopsin‐2 (ChR2)
into human induced pluripotent stem cell (hiPSC) derived neural progenitor cells (Axol)
using lentiviruses and cell‐type specific promoters. A mixed population of human
iPSC‐derived cortical neurons, astrocytes and progenitor cells were obtained (Axol‐
ChR2) upon neural differentiation. Pan‐neuronal promoter synapsin‐1 (SYN1) and
excitatory neuron‐specific promoter calcium‐calmodulin kinase II (CaMKII) were used
to drive reporter gene expression in order to assess the differentiation status of the
targeted cells. Expression of ChR2 and characterisation of subpopulations in differen-
tiated Axol‐ChR2 cells were evaluated using flow cytometry and immunofluorescent
staining. These cells were transferred from 2D culture to 3D alginate hydrogel
functionalised with arginine‐glycine‐aspartate (RGD) and small molecules (Y‐27632).
Improved RGD‐alginate hydrogel was physically characterised and assessed for cell
viability to serve as a generic 3D culture system for human pluripotent stem cells
(hPSCs) and neuronal cells. Prior to cell encapsulation, neural network activities of
Axol‐ChR2 cells and primary neurons were investigated using calcium imaging. Results
demonstrate that functional activities were successfully achieved through expression
of ChR2‐ by both the CaMKII and SYN1 promoters. The RGD‐alginate hydrogel sys-
tem supports the growth of differentiated Axol‐ChR2 cells whilst allowing detection
of ChR2 expression upon light stimulation. This allows precise and non‐invasive con-
trol of human neural networks in 3D.
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2 LEE ET AL.1 | INTRODUCTION
The adult brain has very limited regenerative capacity, which is
insufficient to prevent the progression of neurodegenerative diseases,
such as Alzheimer's and Parkinson's disease or restore neuronal function
following damage derived from stroke or traumatic brain injury (Vink &
Bullock, 2010). Traditional treatments for neurodegenerative diseases
and traumatic brain injury mainly rely on drugs to reduce the rate of
degeneration (Kikuchi, Uchikado, Morioka, Murai, & Tanaka, 2012; Van
der Schyf, 2011). In order to overcome neurological disorder and defi-
ciency, generation of functional neuronal cells in three‐dimension (3D)
combined with optogenetic targeting is a cutting‐edge strategy, not only
aimed for treatment through tissue implantation and neuromodulation
but also as an in vitro model for drug screening and disease modelling.
In neuroregeneration, human pluripotent stem cells (hPSCs) such
as embryonic stem cells (ESCs) and induced pluripotent stem cells
(iPSCs) are promising cell sources due to their self‐renewal characteris-
tics and their capability to give rise to neural progenitor stem cells and
differentiate to all types of neuronal cells. Homogeneous neuronal
populations can be obtained through use of a range of differentiation
media and protocols, however, it is often a challenge to generate elec-
trophysiologically active neurons. Many studies have demonstrated
efficient differentiation of hPSC and neural progenitor cells to dopami-
nergic neurons and astrocytes (DA) in vitro via various strategies either
on 2D monolayer cultures, co‐cultures with stromal cell lines (PA6
cells), or on 3D extracellular matrices (Cho et al., 2008; Murphy, Laslett,
O'Brien, & Cameron, 2017). However, excitatory glutamatergic neu-
rons involved in synaptic functions have not been extensively investi-
gated in tissue engineering and specific‐cell targeting. Specific
targeting of glutamatergic neurons in the mixed neuronal population
is made possible by using an optogenetic approach.
Optogenetics is a novel technology that integrates genetic and opti-
cal engineering to achieve both high temporal and spatial precisionwithin
neuronal tissues, overcoming many of the limitations of conventional
electrical stimulation and pharmacological methods. Optogenetics facili-
tates targeting and manipulation of specific neuronal sub‐populations,
such as excitatory and inhibitory neurons. Moreover, the brain tissues
of conscious animals can be controlled by the expression of light‐
sensitive genes such as channelrhodopsin‐2 (ChR2), which triggers mem-
brane depolarisation upon illumination with 470 nm wavelength blue
light. ChR2 has been applied to neuroscience research for imaging,
targeting specific neurons within neural networks, monitoring neural
developments, and regulating neural network activity (Steinbeck et al.,
2015). In stem cell engineering, optogenetics has been used for tracking
the differentiation of stem cells, for functional analysis of embryonic
stem cell‐derived grafts, as well as for testing the functional integration
of induced pluripotent stem cell‐derived neurons (Colasante et al., 2015).
Efficient gene delivery and expression of ChR2 in neuronal cells has
been demonstrated using lentiviral vectors with neuron‐specific pro-
moters (Hioki et al., 2007). Lentiviral vectors with five different types of
neuron‐specific promoter: synapsin I (SYN1), calcium/calmodulin depen-
dent protein kinase II (CaMKII), tubulin alpha I (Ta1), neuron‐specific eno-
lase (NSE), and platelet‐derived growth factor‐beta chain (PDGF) have
been generated by fusing neuron specific elements with the cytomegalo-
virus enhancer element (Gloster et al., 1994; Lee et al., 2010; Sasaharaet al., 1991). Among these promoters, CaMKII is specifically active in glu-
tamatergic neurons, whereas pan‐neuronal promoters are active in all
neural types. In this study, CaMKII and SYN1 promoters were selected
to establish optogenetic control of hPSC‐derived neural networks. This
led to the downstream induction of ChR2 expression facilitating the sub-
sequent effect on the regulation of neural activity of hPSC‐derived neural
networks to be compared.
Furthermore, generation of neurons in 3D requires bioactive scaf-
folds combined with support cells to maintain hPSC viability and neural
differentiation, leading to a functional neural network that imitates those
in the human brain. It is a challenge to improve the microenvironment of
3D culture for optimal survival of optogenetically engineered cells.
Hydrogels have been reported as efficient cell carriers or growth factor
delivery vehicles in brain tissue engineering (Cheng, Chen, Chang, Huang,
& Wang, 2013). In addition, their mechanical properties are comparable
with those of human brain tissue (Aurand, Wagner, Lanning, & Bjugstad,
2012), being soft and supportive for cell growth. Cell encapsulation in a
hydrogel is, therefore, a promising therapeutic approach that can be
applied for culture in vitro or transplanted in vivo.
In this study, alginate hydrogel was utilised for 3D culture of
optogenetically modified neurons derived from hPSCs. Previous studies
have demonstrated that human embryonic stem cells (hESCs) can be
propagated and differentiated in 3D culture using alginate microcapsules
(Chayosumrit, Tuch, & Sidhu, 2010; Dean, Yulyana, Williams, Sidhu, &
Tuch, 2006). Alginate supports the survival of encapsulated cells in
high‐density cultures through allowing rapid exchange of nutrients, oxy-
gen, and stimuli across the outer layer of themicro‐capsule. Encapsulated
cells are buffered in vivo from external factors such as antibodies from
the host (Serra et al., 2011). Furthermore, it has been shown that the algi-
nate encapsulation promotes cell growth, differentiation,maturation, and
protein secretion of various cell types including mesenchymal stem cells,
mouse ESCs, and human ESCs (Addae et al., 2012; Serra et al., 2011).
Despite success in the growth support ofmany cell types, studies utilising
alginate encapsulation for hiPSC differentiation and 3D culture are lim-
ited (Addae et al., 2012; Chayosumrit et al., 2010).
In order to improve the ability of alginate hydrogel to support cell
attachment and differentiation, alginate hydrogel has been functionalised
with Arginylglycylaspartic acid (RGD) peptide. The RGD peptide
sequence is foundwithinmany cell adhesive proteins within the extracel-
lular matrix, acting as an integrin binding sites that mediate cell adhesion
and increase cell‐matrix interaction (Ruoslahti, 1996). The physical con-
formation of the RGD loop regulates the affinity of integrin binding, hav-
ing a direct effect on cell adhesion (Hersel, Dahmen, & Kessler, 2003).
RGD and other peptide ligands such as YIGSR (Tyr‐Ile‐Gly‐Ser‐Arg) and
IKVAV (Ile‐Lys‐Val‐Ala‐Val) have been reported as crucial in neural pro-
genitor cell survival and differentiation (Li et al., 2014; Villard et al., 2006).
Improving cell integrin within the alginate hydrogel alone is
insufficient for optimal culture of hPSCs. Cell survival within alginate
hydrogel, particularly hPSCs, can be further enhanced by inhibiting
apoptosis using individual or multiple small molecules such as
through the use of Rho‐associated kinase inhibitor (ROCKi, Y‐
27632). The use of this small molecule was found to increase the
viability of dissociated hESCs (10 μM) and several cell lines such as
glioblastoma (U87‐MG), patient‐derived glioblastoma xenoline
(JX12), primary glioblastoma (SMC448), and non‐cancerous
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et al., 2015; Watanabe et al., 2007). The anti‐apoptotic effect of Y‐
27632 in feeder‐free culture, and its effect in pro‐expansion of most
stem cell types has been successfully demonstrated (Watanabe et al.,
2007), however, the incorporation of ROCKi into the alginate hydro-
gel had not been previously applied.
The aim of this study was to investigate the use of neural sub‐
population specific promoters to drive ChR2 expression in hiPSC‐
derived neurons (Axol‐ChR2) after being encapsulated in the
functionalised alginate hydrogel (RGD + ROCKi). We examined whether
these cells survived and matured into active neurons/neural networks
that respond to light stimulation, both in 2D and 3D culture. Results
demonstrate that cells survive with optical excitability and show neural
calcium‐flux functionality in both 2D and 3D culture systems.2 | MATERIALS AND METHODS
2.1 | Culture and differentiation of human
pluripotent stem cells
Human embryonic stem cells, (HUES2 cell line) were obtained from
Harvard University, Melton Lab, Massachusetts, United States. The
use of HUES2 to conduct human stem cell research was approved
by the ethical committee at the University of Oxford. The cells
(1 × 106 cells/ml in hESCs medium) were co‐cultured on a mouse
embryonic fibroblast feeder layer and incubated at 37°C without
disturbance. Cells were treated with ROCKi, Y‐27632 (Calbiochem,
California, United States) at 10 μM. Medium was changed daily
(replaced with 50% of fresh medium) for 6 days before subculture or
transfer to matrigel (feeder free culture) in mTeSR1 medium (Stemcell
Technologies Inc., France). The mTeSR1 medium was changed daily
until hESC cells reached 80% confluence, cells were then passaged
using accutase to create single cell suspensions (Invitrogen, United
States). Cells were expanded in culture prior to encapsulation with
alginate hydrogel. In contrast, human induced pluripotent stem cell‐
derived neural progenitor cells (hiPSC‐NPC; AXOL13 and AXOL15 cell
lines), purchased from Axol Bioscience, Cambridge, United Kingdom.
HiPSC‐NPC cells (50,000 cells/cm2) were plated onto laminin coated
six‐well plates (Sigma, United States) in Axol plating‐XF medium for
24 hr. Cultures were maintained in Axol neural maintenance‐XF
medium (up to 50 days) until differentiation in Axol neural
differentiation‐XF medium for 72 hr to obtain mature neurons.
2.2 | Preparation of primary neurons
The dissociated hippocampal cells were gifts from Fabio Biachi (Oxford
University), isolated from 14.5‐day pregnant mice according to the local
established ethical policies. The individual embryos were separated by
cutting uterus between embryo locations and kept in cold neural basal
media (NB media). An incision was made in embryo head to dissect the
brain in half via the sagittal midline. The meninges were removed, and
the hippocampus was removed into NB media on ice. Hippocampi in
NB media were centrifuged at low speed (500 rcf) for 2 min following
by enzymatic digestion with trypsin for 25 min at 37°C and stirredevery 5 min to create a homogeneous mixture. Enzymatic activity was
then neutralised, and the tissues were triturated using a fine Pasteur
pipette coated with fetal bovine serum to obtain a single cell suspen-
sion. Cells were centrifuged and resuspended in complete NB media
prior plated on PLO/laminin coated dishes for expansion.2.3 | Cell modification using optogenetics
The channelrhodopsin‐2 (ChR2) gene was fused to enhanced yellow
fluorescent protein (eYFP) and cloned into a lentivirus expression
plasmid with cell type‐specific promoter (a) pan‐neuronal promoter,
pLenti‐synapsin1‐hChR2‐(E123T‐T159C)‐EYFP‐WPRE and (b)
glutametergic neuron promoter, pLenti‐CaMKII‐hChR2‐(E123T‐
T159C)‐EYFP‐WPRE, driving ChR2‐eYFP expression in the specific
cells. The universal or constitutive promoter of human origin, human
elongation factor‐1 alpha (EF1a), was included in the study. The trans-
fer vectors of ChR2 constructs were a gift from Dr David Nagel.
Lentiviral production was performed according to the standard proto-
col. Viral particles were centrifuged at 500 rcf for 10 min, then resus-
pended in OPTI‐MEM, filtered, and titrated using an enzyme
immunoassay, HIV p24 antigen ELISA (Cell Biolabs' QuickTiter™ Len-
tivirus Titer Kit). The hiPSC‐NPCs (AXOL13) were incubated with
respective amount of viruses (multiple of infection‐1 [MOI‐1] and mul-
tiple of infection‐2 [MOI‐2]) for first infection in 24 hr and second
infection in the following 24 hr. Transduction efficiency of
differentiated ChR2‐positive Axol cells (Axol‐ChR2) was evaluated
using flow cytometry and fluorescent microscopy after 14 days
of transduction.2.4 | Flow cytometry
Axol‐ChR2 cells: Axol cells transduced with lentiviral vectors encoding
the ChR2 gene under control of the SYN1, CaMKII, and EF1a pro-
moter, were produced by transduction at MOI‐1 and MOI‐2. Cells
were enzymatically detached from culture at Days 7, 14, and 28,
washed with culture medium, and immersed in phosphate buffer
saline (PBS, pH = 7.4) before quantifying the level of transduction by
flow cytometry (BD FACSCalibur). Untreated cells or non‐transduced
cells were used as a negative control to establish positive gate regions.
Positive cells were those in positive gate regions, the proportion of
positive cells as a percentage of live cells is given. A minimum total
of 10,000 live events were acquired for each sample. Data were
analysed with BD CellQuest™ Pro Software.2.5 | Immunofluorescent staining
Optogenetically engineered hiPSC‐NPCs were differentiated to
neurons (Axol‐ChR2 cells containing SYN1/CAMKII promoter) and
fixed with 4% paraformaldehyde in PBS for 30 min at room tempera-
ture (RT). The cells were permeabilised and blocked (5% BSA, 0.2%
Triton‐X100, and 0.1% tween 20 in PBS) for 1 hr and incubated over-
night in primary antibody solution at 4°C. Cells were washed three
times with wash buffer (0.2% BSA, 0.2% Triton‐X100, and 0.1%
Tween 20 in PBS) and then blocked with 10% goat serum in wash
4 LEE ET AL.buffer for 30 min. Secondary antibody solution was added, and cells
were incubated at RT for 2 hr. Finally, the cells were washed with
washing buffer and stained with 300 μl of 6‐diamidino‐2‐phenylindole
(DAPI). Pictures were taken using confocal microscopy (Zeiss‐LSM
780, Germany) and analysed with ZEN light 2013 software.
The primary antibodies used were mouse anti‐neuron‐specific class
III beta‐tubulin (Tuj1 for neural cytoskeleton; 1:1,000; abcam, Cambridge,
United Kingdom, www.abcam.com), mouse anti‐γ‐aminobutyric acid B
receptor 1(GABA‐B‐R1 for inhibitory neurons; 1:50; abcam), rabbit
anti‐S100B (1:200; abcam), rabbit anti‐glial fibrillary acidic protein (GFAP
for astrocytes; 1:2500; abcam), and rabbit anti‐vesicular glutamate trans-
porter 1 (vGlut1 for excitatory neurons; 1:100; abcam). Secondary anti-
bodies: Alexa Fluor®568‐conjugated goat anti‐mouse, Alexa
Fluor®649‐conjugated goat‐anti rabbit, and Alexa Fluor®488‐
conjugated goat anti‐rabbit were all used at 1:500 (Invitrogen, LifeTech-
nologies, Grand Island, New York, www.lifetechnoogies.com). Negative
controls for the samples were prepared in the same staining protocol,
containing no primary antibody but only secondary antibody.2.6 | Fabrication and functionalisation of alginate
hydrogel
High molecular weight ultrapure alginate (Pronova‐MVG) was
obtained from Pronova Biomedical, Oslo, Norway (Mw = 231 kDa,
high guluronic acid content, medium viscosity >322 cP). Alginate was
dissolved in 0.9% (w/v) sodium chloride (NaCl) at 60°C for 6 hr, and
autoclaved. A stock solution of 2.0% (w/v) was prepared and diluted
to 1.2%, 1.4%, 1.6%, and 1.8% (w/v), respectively. Alginate solutions
were transferred to a 5 ml syringe connected to a syringe pump (Har-
vard apparatus, United States) at a distance of 7 cm from the gelling
bath. To polymerise the gel into beads, the solutions were extruded
into 102 mM calcium chloride (CaCl2) on a stir plate using 30‐gauge
needle at different flow rates (2, 2.5, and 3 ml/min) and gently stirred
for 7 min at room temperature. The beads were washed with sodium
chloride twice and immersed in PBS for microscopic analysis.
RGD peptide was conjugated to alginate via an amide bond
between the terminal amine (NH2) of peptide and the carboxylate
(COOH) on alginate. The functionalisation of alginate utilised aqueous
1‐ethyl‐3‐[3‐dimethylaminopropyl] carbodiimide (EDC) chemistry
(Rowley, Madlambayan, & Mooney, 1999). Sulfo‐NHS (0.1 mmol),
EDC (0.2 mmol) and RGD peptide were added into the alginate‐MES
buffer, and the reaction was performed for 20 hr. The RGD‐alginate
solution was purified by dialysis (3,500 molecular weight cut‐off)
against distilled water (dH2O) in decreasing salt solution concentra-
tions for 72 hr, then lyophilised for 24 hr and stored desiccated until
use. The RGD‐alginate was incorporated with ROCKi (10 μM) in the
culture medium during cell encapsulation.2.7 | Characterisation of alginate hydrogel
2.7.1 | Physical measurement
Alginate beads were characterised using microscopic analysis (Nikon
eclipse Ti, Japan) to measure the bead size. Mean diameter (n = 50)was calculated to determine the bead size at different concentrations
(1.2%, 1.4%, 1.6%, 1.8%, and 2.0%) and flow rates (2, 2.5, and
3 ml/min).
2.7.2 | Cell viability assay
The hESCs (HUES2 derived from feeder‐free layers) and hiPSC‐NPC
cells (Axol) were harvested as single cells using accutase, resuspended
in 1.8% alginate and RGD‐alginate solutions, prior to extrusion into
102 mM CaCl2 at a flow rate of 3 ml/min. Beads encapsulated with
hESCs or Axol cells were rinsed with PBS twice, transferred to a six‐
well dish and cultured in a chemically‐defined condition (mTeSR1
medium containing ROCKi was used for hESCs whereas Axol neural
maintenance‐XF medium containing ROCKi was used for Axol cell cul-
ture). The constructs were removed from culture medium (500 μl per
well), stained with calcien‐AM and propidium iodide (PI) solution
(Sigma Aldrich, Missouri, United States) at 37°C for 1 hr. The
constructs were rinsed and immersed in PBS for confocal imaging
(Zeiss‐LSM 710) using ZEN light 2011 software. Pictures were taken
at the equatorial plane using a 5x objective. The percentage of
surviving cells was determined by dividing the number of cells stained
green by the total number of cells (stained green and red) at a
sectional‐view using ImageJ software (National Institutes of Health,
Bethesda, Maryland). The experiments were carried out in triplicate,
and results were analysed using Prism5.2.8 | ChR2 stimulation and calcium imaging
Live calcium imaging was performed with CAL‐590 (AM, Mw‐
1129.86, ATT Bioquest). Transduced and nontransduced Axol cells
and primary neurons (positive control) were incubated with CAL‐
590 AM at a concentration of 10 μM (solubilised in DMSO and
prepared with Pluronic F‐127) in artificial cerebrospinal fluid (ACSF)
for 40 min at RT. The cells were washed and incubated in ACSF and
imaging was carried out using a Carl Zeiss 780 confocal microscope.
The set‐up was as follows: 20x objective, Zoom 1, 512 × 512 format,
8‐bit resolution, xyt scan mode, 400 Hz speed, 1.0 airy pinhole, frame
average 1, line average 4 for image, and 1 for time lapse imaging.
Optogenetically modified and unmodified cells in 2D and 3D were
excited with 540/565 nm laser for ion calcium indicator (CAL‐
590 AM), and 488 nm laser (at 20% laser power) to detect the yellow
fluorescence from eYFP whereas 100% 488 nm laser power was set to
stimulate the ChR2‐eYFP. Time lapse imaging was set with a stimula-
tion of 1.635 s, and a total of 200 frames were recorded at the basal
ion calcium level.2.9 | Statistically analyses
The data in this study were analysed using SPSS 10 software (SPSS
Inc., Chicago, United States). Student's t test was used for
comparisons between two groups. ANOVA followed by Tukey's post
hoc test was used for comparisons among the groups. Statistical sig-
nificance was accepted at p < 0.05, unless otherwise stated. All
experiments were performed in triplicate.
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3.1 | Lentiviruses‐mediated expression of
ChR2‐eYFP in neurons derived from human iPSCs
(Axol cells)
The expression level of ChR2‐eYFP was higher in Axol cells driven by the
SYN1 promoter (6.5%) than the CaMKII promoter (2–5%) at MOI‐2 from
Days 7–28 after transduction (Figure 1a), indicating that the pan‐
neuronal promoter SYN1 was a stronger promoter in these cells than
CaMKII. The expression resulting from regulation by the positive control
universal promoter EF1a led to a two fold (>13%) increase in ChR2‐eYFP
expression in comparison with the levels of expression regulated by the
SYN1 and CaMKII promoters in Axol cells (Figure 1b). The transduction
condition MOI‐2 is found to be more efficient than MOI‐1. On Day 14
of transduction, strong ChR2 signals were expressed (Figure 1a–c), and
mature neuronal morphology was indicated by the presence of gluta-
matergic and GABAergic cells in the differentiated optogenetically‐
modified Axol cells. Confocal microscopy showed the distribution of
ChR2‐eYFP/GFP expression in the cell membrane and along the den-
drites. Results suggested that the neurons needed to be cultured for at
least 14 days following transduction before optical stimulation and
downstream analyses (Supplementary Figure 1). The differentiated neu-
rons at Day 7 post‐infection lacked maturity, with low neural network
activity that made them unsuitable for light stimulation and recording.
Factors such as neural maturity, stability of ChR2 expression, and net-
work connectivity needed to be taken into consideration, which required
the treated cell to mature in the culture for longer periods.3.2 | Optogenetic engineered Axol cells exhibited
characteristics of mature neurons
In order to better characterise cellular phenotype, immunofluorescent
staining of Axol‐ChR2 cells containing different promoters (between
passages 8 and 10) was performed. The transgene ChR2‐eYFP was
expressed in both pSYN1‐ChR2‐eYFP and pCaMKII‐ChR2‐eYFP
driven Axol cells. The cells were stained strongly positive for the
mature neural markers ßIII‐tubulin (TuJ1) and glial fibrillary acidic pro-
tein (GFAP/S100β; Figure 2). High expression of GABAergic cells
(GABA) and low signals of glutamatergic cells (vGlut1) were observed
in Axol‐ChR2 cells driven by SYN1. Vice versa, high expression of glu-
tamatergic cells (vGlut1) and low signals of GABAergic cells (GABA)
were shown in Axol‐ChR2 cells driven by CaMKII (Figure 2). Results
indicated successful differentiation of inhibitory and excitatory neu-
rons from hiPSC‐NPCs, with both SYN1 and CaMKII promoters
driving the expression of ChR2 in their specific neuronal subtype.3.3 | Concentrations and flow rates regulate the
diameter of alginate bead in 3D cell culture
Alginate beads were optimised to produce suitable bead diameter
and morphology for 3D culture of hPSCs. Diameters ranging from
700–2,500 μm were obtained from alginate derived from high
guluronic acid or G content (UP‐MVG; Figure 3a). Bead diameterwas adjusted by changing alginate concentrations and flow rates. A
significant correlation between the two parameters was identified:
The higher the flow rate, the smaller the bead diameter. The bead
diameter increased constantly and proportionally to concentration at
lower flow rates (2 and 2.5 ml/min). The data indicated that the
highest flow rate, set at 3 ml/min in the study, played a critical role
in reducing the bead diameter in all concentrations. However, the
bead morphology and satellite fraction content were modulated by
the concentration. The beads were produced with rounder shapes at
higher concentrations than at lower concentrations, whereas the for-
mation of satellites (tails) was only found at 1.2% (Figure 3b).
Small beads with diameters of less than 1,000 μm are favourable,
decreasing the diffusion distance to the center of the bead and
increasing the surface‐to‐volume ratio. Use of alginate derived from
a 1.8% concentration solution and at a flow rate of 3 ml/min was
found to produce beads with an average diameter 800 μm was chosen
as optimal to satisfy the quality requirements of bead integrity, size,
spherical morphology, and with no presence of satellite fraction.3.4 | Cell viability increased in RGD functionalised
alginate
Cells were initially encapsulated within alginate at a density of 2 × 106
cells/ml, and the total viable cells were measured by live‐dead cell stain-
ing along the time course. The growth of HUES2 is very sensitive to the
microenvironment and changes within the cell niche (Gattazzo, Urciuolo,
& Bonaldo, 2014). Functionalised alginate hydrogels with RGD in this
study appeared to support the viability of HUES2. Cell viability of HUES2
in RGD‐alginate was significantly increased (p < 0.01) on Day 14 when
compared with unmodified alginate and to the early stage of 3D culture
(Day 3; Figure 4a). The results demonstrated that conjugated RGD pep-
tide enhanced HUES2 attachment and cell survival in the alginate beads,
in agreement with previous studies also using hPSCs (Hwang, Varghese,
Zhang, & Elisseeff, 2006; Lee & Mooney, 2001). The pluripotency of
HUES2 was evaluated for OCT‐4, NANOG, ALP, and SSEA‐4 (Positive
expressions are reported in Supplementary Figure 2A and 2B). The
HUES2 cells exhibited expression of βIII‐tubulin at Day 14 and Day 21
after neural differentiation (Supplementary Figure 2C).
Axol cells showed higher cell viability than HUES2 in the RGD‐
alginate system. Cell viability increased and was maintained at between
45 and 50% at Day 7 and Day 14 in the culture (Figure 4b). The viability
of Axol cells encapsulated in alginate without RGD was similar to that
observed for HUES2 cells, dropping significantly by Day 14 (p < 0.01).3.5 | ChR2‐eYFP expression remained when culture
in 3D RGD‐alginate
Optogenetically modified neurons (Axol‐ChR2 cells) were further
investigated for their potential to establish a 3D culture
network culture model by encapsulating these cells into RGD‐alginate
beads. Confocal microscopy revealed that expression of eYFP‐ChR2
by transduced Axol cells was not affected by the culture environment,
or by bead diameter (Figure 5a). The Axol‐ChR2 cells were found clus-
tered in spherical aggregates within the RGD‐alginate beads,
FIGURE 1 Expression of fluorescent tagged ChR2 in 2D neural cultures of transduced Axol cells under different promoters: channelrhodopsin‐2‐
enhanced yellow fluorescent protein‐synapsin‐1 (SYN1), ChR2‐eYFP‐calciumcalmodulin kinase II (CaMKII), and ChR2‐GFP‐elongation factor‐1 alpha
(EF1a). (a) Transduction efficiency was assessed using flow cytometry and the graphs show positive ChR2 expression quantified for each time point.
Expression of the universal promoter, EF1a was used as a positive control. Axol cells were transduced using different conditions, and with one or two
multiplicities of infection (MOI‐1 andMOI‐2). Significancewas assessed using ANOVA; * = p < 0.05; Error bars denote standard deviation (±SD), n = 3. (b) An
example showing how gating was used to quantify flow cytometry results for eYFP‐ChR2 expression under the SYN1 promoter. Nontransduced cells were
used in setting the gating region, andChR2‐eYFP positive neuronswere quantitated. (c) Fluorescent imaging reveals that ChR2was distributed evenly. Cells
were imaged using a fluorescence microscope (Nikon EclipseTi‐E, Japan). Negative controls: images of non‐transduced cells taken using identical setting,
indicate that positive signal does not arise from non‐specific fluorescence. Scale bar: 50 μm [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 2 Immunofluorescent staining of human induced pluripotent stem cell‐derived neurons (Axol) demonstrating positive expression of
neural markers TuJ1, GFAP/S100β, GABA (low expression under calcium calmodulin kinase II [CaMKII] promoter) and vGlut1 (low expression
under synapsin‐1 [SYN1] promoter) under the control of different neuronal‐specific promoters. Axol cells containing pSYN1‐ChR2‐eYFP and
pCaMKII‐ChR2‐eYFP were cultured on a laminin coated 24‐well, glass‐bottom plates, and matured in Axol differentiation and maintenance
medium for 3–6 weeks. The cells were fixed, permeabilised, and stained with identifying markers shown in green depicting the neural cytoskeletal
(TuJ1), astrocytes (GFAP/S100ß), GABAergic neurons (GABA), and glutamatergic neurons (vGlut1). ChR2‐eYFP is depicted in yellow whereas cell
nuclei are depicted in blue (DAPI). Fluorescent images were captured using confocal microscopy (Zeiss‐LSM 710) and processed with ZEN light
2011 software. Scale bar: 50 μm [Colour figure can be viewed at wileyonlinelibrary.com]
LEE ET AL. 7however no outgrowth of neurites was observed after 24 hrs of
encapsulation. The cells were characterised using progenitor and neural
markers at different passages. Upon neural differentiation, Axol cells at
Passage 10 showed higher expression of mature neurons (VGluT‐1)
with approximately 50% (p < 0.5) when compared with Pax‐6 and
Nestin (Figure 5b).3.6 | Neural network‐forming capability on 2D and
3D culture
The neural network‐forming capability of optically excitable iPSC‐
derived neurons (Axol‐ChR2 cells) in 2D cultures and 3D encapsulated
in the RGD‐alginate hydrogel was evaluated using calcium imaging.
FIGURE 3 The effect of alginate concentration (%) and flow rate (ml/min) on the diameter of beads derived from high guluronic acid alginate (UP‐
MVG, n = 50). (a) Graph showing the effect of alginate concentration and solution flow rate though the needle on bead diameter and roundness. The
smallest diameter alginate beads with spherical morphology were formed using the highest flow rate (3 ml/min) at a solution concentration of 1.8%
(N = 3). Significance was tested by two‐way ANOVA *** = p < 0.001; error bars denote standard error of the mean (± SEM). (b) Brightfield microscopy
images showing the physical morphology of UP‐MVG alginate beads synthesised at different concentrations of alginate and different flow rates.
Formation of satellite fraction or tails (arrow) appeared at the lowest concentration of 1.2%. Figure shows representative images depicting the entire
population of alginate beads (n = 15) (Nikon EclipseTi‐E, Japan). (c) Fluorescent microscopy images representative of HUES2 cells cultured in alginate
beads after 14 days. HUES2 cells showed higher viability in RGD‐alginate modified beads than alginate beads, and viable cells appeared in very small
aggregates. Calcein‐AM stained for live cells (green); propidium iodide, PI stained for dead cells (red). Images were captured using confocal
microscopy (Zeiss‐LSM 710) and processedwith ZEN light 2011 software. Scale bar: 500 μm [Colour figure can be viewed at wileyonlinelibrary.com]
8 LEE ET AL.The action potentials (AP) of the cells were detected with Cal‐590 dye
(red) whereas the green fluorescence signal indicated the location of
ChR2‐eYFP expression at the membrane and within the neurites ofthe cells (Figure 6a). In 2D culture, optogenetically modified primary
neurons exhibited active and repetitive firing upon light stimulation
under the control of SYN1 and CaMKII promoters (Figure 6b,c). Similar
FIGURE 4 3D culture of hESCs (HUES2) and hiPS‐NPC (Axol cells)
in RGD‐alginate showed higher viability than unmodified alginate in
14 days of culture. (a) RGD‐alginate beads increased cell viability of
encapsulated HUES2. (b) Axol and Axol‐ChR2 cells demonstrated
higher viability in RGD‐alginate than alginate. Live cells were stained
with Calcein‐AM (green); dead cells were stained with propidium
iodide, PI (red). Images were captured using confocal microscopy
(Zeiss‐LSM 710) and processed with ZEN light 2011 software. The
percentage of surviving cells was determined by the number of green
signals divided by the total number of cells (green and red signals) and
analysed using a sectional‐views in ImageJ software. Significance was
tested by ANOVA; ** = p < 0.01; n.s. denoted a non‐significant value
and error bars represent standard deviation (± SD)
LEE ET AL. 9results were obtained in Axol‐ChR2 cells, however, higher neuronal
activity was observed in cells with the expression of ChR2 driven by
the CaMKII promoter. These experiments indicate successful neuronal
specific cell targeting using optogenetics.
Further measurement demonstrated that the number of calcium
spikes, consisting of both single and multipeak spikes, increased
significantly upon stimulation in both primary neurons expressing ChR2
(driven by SYN1 and CaMKII promoter) and Axol‐ChR2 cells (driven by
CaMKII with mostly single spikes generated by cells expressing ChR2
driven by the SYN1 promoter; Figure 7a). Upon light stimulation, primary
neurons with ChR2 expression driven by the SYN1 promoter showed a
higher number of single peak andmultipeak calcium spikes in comparison
to primary neurons with ChR2 expression driven by the CaMKII pro-
moter. In contrast, higher calcium flux activity was driven by the CaMKII
promoter in Axol cells (Figure 7b). A single peak represents a complete
AP. The type of calcium peak and AP is presented in Figure 7c whereas
the classification of calcium event is described in Supplementary Figure 3.
Calcium imaging recordings revealed that neural activities of light‐
stimulated Axol‐ChR2 cells in the RGD‐alginate hydrogel appeared in
mixed and burst calcium waves, whereas non‐stimulated cells exhib-
ited slow undefined waves (Figure 6d). Upon stimulation, the numberof calcium spikes (single peak and multipeak) increased significantly,
driven by the SYN1 and CaMKII promoters (Figure 8). A higher num-
ber of single peak spikes was recorded in encapsualted Axol‐ChR2
cells driven by the CaMKII promoter, thought to indicate the presence
of a greater number of functionally mature neurons in the culture.4 | DISCUSSION
In this study, we demonstrated that the human iPSCs derived neural
progenitor cells successfully differentiated into neurons that
expressed ChR2 driven by the neuronal specific SYN1 and CaMKII
promoters. The expression of ChR2 under the control of the SYN1
and CAMKIII promoters, maturation, and electrical activity of the
optogenetically engineered neurons were evaluated in both 2D cul-
tures and 3D hydrogel cultures.
The delivery of ChR2‐eYFP into human iPSCs derived neurons
was mediated by lentiviruses. Transduction at MOI‐2 and MOI‐1
followed by re‐infection did not induce significant cell death but
achieved high expression of ChR2‐eYFP. Both cytosolic eYFP and
membrane‐bound ChR2 were localised throughout the entire cell
(somata and neurites). Similar results have been demonstrated by Uzel
and colleagues in the optogenetic targeting of ESC and the optical
excitability of ChR‐H134R‐ESC‐derived motor neurons (Uzel et al.,
2016). Furthermore, Rapti and colleagues have compared the major
viral vectors of adeno‐associated viruses, adenoviruses, and lentivi-
ruses using various undifferentiated cells (hPSCs: hES2, H9, hiPS31.3,
hiPS24.1) and differentiated cells (cardiomyocyte derivatives). Their
findings agreed that lentiviral vectors transduced all cell types with
moderate efficiency (Rapti et al., 2015). Other research groups have
reported that ChR2‐ESC‐derived neurons displayed strong ChR2‐
expression, mature neuronal morphology, and positive expression of
vGlut2 marker (Stroh et al., 2011), and this is in agreement with our
findings from the use of lentivirus transduction on ChR2‐iPSC‐derived
neurons (Axol‐13 cell line). Other studies have also reported the
robust expression of SYN1 promoter in various types of neuronal cells
including hPSC‐derived neurons (Steinbeck et al., 2015).
Following transduction, human iPSC derived neural progenitor
cells were differentiated to distinct neuronal phenotypes with positive
expression of neuron‐specific tubulin (TuJ1) and astrocytes markers
(S100B/GFAP). Mature glutamatergic and GABAergic neuronal sub-
types, were observed, indicating the presence of excitatory and inhib-
itory neurons. Although optogenetic approaches have recently been
used for in vivo and in vitro study in neuroscience (Steinbeck et al.,
2015), it is novel to apply this strategy to generate an in vitro 3D neu-
ral culture model. Furthermore, the 3D culture system developed
using modified alginate hydrogels (alginate functionalised with RGD
and ROCKi showed potential in supporting cell survival and allowing
neural networks to be light‐stimulated in 3D culture.
Prior to culture with cells, the physical properties of alginate
hydrogel (bead size, sphericity and consistency of formation) were
characterised. Results revealed that the physical properties of the
hydrogel correlate to chemical composition, and specifically to the
proportion of guluronic to mannuronic acid residues in alginate. Algi-
nate consisting of a higher guluronic acid and purity (UP‐MVG) forms
FIGURE 5 ChR2‐eYFP positive expression of Axol cells differentiated from hiPSC‐NPCwas retained in the 3D culture system. (a) Top: Microscopy
images showing fluorescent tagged ChR2 expressing cells (green) inside single alginate beads. Optogenetically modified Axol cells cultured in 2D
were enzymatically detached and encapsulated within RGD‐alginate beads. The constructs were examined using a confocal microscope (Zeiss‐LSM
710) to investigate the expression of ChR2‐eYFP, cell morphology and distribution within the 3D culture system. Non‐transduced Axol cells were
used as a control. (a) Bottom: Merged images showing fluorescent images combined with brightfield phase‐contrast images; scale bars: 100 μm. (b)
Graphs showing how thematuration of neurons increased during passaging (P6–P10) in neural differentiationmedium. The heterogeneous Axol cells
were harvested from different passages to determine cell phenotype spreadwithin their cell populations using flow cytometry (N = 3). The cells were
stained with progenitor stem cell markers (Pax‐6 and Nestin) and neural marker (vGluT1) to assess neuronal maturation over passaging and culture.
Unstained cells were used as a control and to set gate regions. ANOVA was used to assess significance. A *p‐value below 0.05 was considered
statistically significant. Error bars indicate standard deviation (± SD) [Colour figure can be viewed at wileyonlinelibrary.com]
10 LEE ET AL.stiffer gels and rounder beads, and this enables the physical properties
of alginate to be maintained for a longer period of culture. In line pub-
lished reports, it was found that microspheres produced from highly
purified alginate has less morphological imperfections, resulting in the
production of more spherical beads with smaller diameters (Kendall,
Darrabie, El‐Shewy, & Opara, 2004). Although increasing the concen-
tration of alginate correlated directly with an increase in bead size, flow
rate was found to exert a significant influence on bead diameter. The
bead diameter was optimised for cell encapsulation and culture, to
enable rapid nutrient and gas diffusion through the alginate. Using the
optimised parameters, the parameters alginate bead diameter
(800 μm) falls within the range of 600–1,000 μm, where glucose,
ammonia, and vitamin B have been found to rapidly diffuse across the
outer layer of the bead (Gautier et al., 2011).Other bead production parameters such as needle size also con-
tributes to the shape and size of alginate beads. A larger diameter
needle (25G, 5/8″) may lead to bead deformation (tailing), which is a
very common phenomenon found with the use of viscous alginate
solutions (Fundueanu, Nastruzzi, Carpov, Desbrieres, & Rinaudo,
1999). When a smaller diameter needle (30G, 1/2″) was used for
extrusion of the beads, the beads with the smallest diameter could
be formed with no tailing in combination with use of alginate
formulations of high concentration (1.8%) with high extrusion flow
rate (3 ml/min).
After encapsulation, HUES2 cells in RGD‐modified alginate dem-
onstrated higher viability than those encapsulated in unmodified algi-
nate, as shown by live/dead analyses. This is thought to be because
the RGD sequence acts as a site to bind cell‐membrane integrin
FIGURE 6 Response of Axol cells expressing ChR2‐eYFP driven by both SYN1 and CaMKII promoters to light stimulation. (a) High magnification
image of Axol cells transduced to express ChR2‐eYFP localised in the membrane (green) and loaded with CAL‐590 calcium indicator (red). Samples
were imaged using confocal microscopy at an excitation wavelength of 540/565 nm (Zeiss‐LSM 710). Magnification: 40x. (b) Lower magnification
image showing CAL‐590 calcium dye stained Axol cells cultured in 2D, with five regions of interest (ROI) marked (green circles). Scale bar: 50 μm.
(c) Calcium flux traces of primary neurons and Axol cells, and (d) calcium flux traces of Axol cells in RGD‐alginate expressing ChR2‐eYFP loaded
with CAL‐590 (calcium dye showing traces from two regions of interest for (c) and (d), black line: ROI‐1 and grey line: ROI‐2. The cells were
optically stimulated with a laser at 488 nm every 30 sec (200 frames), and the fluorescence intensity was normalised to the level of baseline
fluorescence measured before the onset of the calcium signal (ΔF/F). Scale = 0.1 ΔF/F (y‐axis); 30 sec (x‐axis); black arrows: light stimulation; scale
bar: 50 μm [Colour figure can be viewed at wileyonlinelibrary.com]
LEE ET AL. 11receptors, resulting in increased cell attachment and viability. It has
previously been shown that bioadhesive sequences, such as RGD
and IKVAV, can increase cell adhesion and growth through the
integrin‐mediated pathway (Li et al., 2014; Villard et al., 2006). One
cause of cell death in the functionalised hydrogels may be apoptosis.
Our findings suggest that whilst alginate hydrogel may support the
culture of other cell types, alginate alone is unable to provide an opti-
mal microenvironment for the growth of hPSCs (HUES2). In this study,
Axol cells survived better than HUES2 in RGD‐alginate. Alginate pro-
vides a promising option for 3D cell cultures with cell viability at 40–
50%. Alginate is a commonly chosen 3D culture substrate, having
favorable characteristics and properties including its ability to make
hydrogels at physiological conditions, transparency for microscopic
evaluation, penetration of light for optical stimulation, gentle dissolu-
tion for cell retrieval, pore networks that allows diffusion of nutrient
and waste as well as its nonanimal origin (Andersen, Auk‐Emblem, &
Dornish, 2015).
Interestingly, encapsulated Axol‐ChR2 cells in RGD‐alginate beads
remained in aggregates with minimal neurite extension. Similar resultshave been observed elsewhere, where the incorporation of the IKVAV
peptide sequence did not lead to an increase in neurite length in silk
fibroid hydrogel after 1 week of differentiation (Sun et al., 2017). This
could be due to structural limitations of the hydrogel, and pore size
should be optimised for the migration and neurite outgrowth of cells
in the future. This study suggests a potential new application of
RGD‐alginate hydrogels in brain tissue engineering. To further
improve alginate hydrogels to support neurite extension it is
suggested that pore size could be optimised. To improve cell attach-
ment, a further approach could be to immoblise different kinds of
peptides in the alginate hydrogel to increase cell adhesion and
neurite outgrowth.
When the cells were transferred from 2D to 3D culture, the
expression of ChR2‐eYFP was found to be stable in the RGD‐
alginate hydrogels, suggesting an initial success towards the
development of a functional 3D neuronal culture model that may
respond to light stimulation. Results show that the cells remained
alive inside the RGD‐alginate hydrogel, and their calcium activities
were detectable. Prior to encapsulation inside the hydrogel, confocal
FIGURE 7 An increase in both the number of single peak and multipeak calcium spikes was observed in optogenetically modified primary
neurons and Axol cells upon optical stimulation. Although the CaMKII promoter was found to drive less overall ChR2 expression than the
SYN1 promoter, CaMKII driven expression was targeted at mature neurons that responded to light stimuli. (a) Calcium waves were analysed from
the ROIs of nonstimulated and stimulated cells derived from transduced primary neurons (Neuron‐ChR2‐SYN1 and Neuron‐ChR2‐CaMKII) and
Axol cells (Axol‐ChR2‐SYN1 and Axol‐ChR2‐CaMKII; ROIs = 40, n = 3). A higher number of burst waves and multipeak calcium spikes was found
to be driven by cells expressing ChR2 containing CaMKII promoter upon stimulation, indicating the presence of mature neurons. Calcium spikes
(single peak and multipeak) were identified from the selected 40 ROIs. Significance was assessed by two‐way ANOVA * = p < 0.05; ns denoted a
non‐significant value and error bars represent standard deviation (± SD). (b) Comparison of single peak and multipeak calcium spikes, respectively
in primary neurons and Axol cells (analysed from the same samples and ROIs used in (a)). (c) Examples of different trace categories, distinguished as
(1) single peak and multipeak, calcium spikes and (2) single or repetitive calcium transient action potentials. The traces represent typical examples
of calcium imaging time series over 5 mins from different ROIs
12 LEE ET AL.imaging revealed that the neurons were able to extend neurites that
formed extensive networks in 2D culture, and that the cells
differentiated into neurons and achieved maturation. Their neural
function and response to light stimulation was confirmed. Results
were also similar to previous studies reported on murine ESC‐ and
hESC‐derived neurons, which display basic neurophysiological activ-
ity in culture, such as AP firing and synaptic currents (Heikkila
et al., 2009; Johnson, Weick, Pearce, & Zhang, 2007).
Upon light stimulation, a normal repetitive pattern of neural
activity was shown in primary mouse neurons (E14.5) indicating that
membrane depolarisation could be triggered by light with ChR2
expression driven by the chosen neuron specific promoters. Expres-
sion of ChR2 in both inhibitory neurons and excitatory neurons was
successfully driven by SYN1 and CaMKII promoters, respectively.
When compared with spontaneous calcium activity of non‐stimulated
primary mouse neurons, non‐stimulated Axol‐ChR2 cells have gener-
ated a lower number of repetitive APs and mixed waves. These results
imply that neural function of Axol cells may require longer time to
mature after being transduced (optogenetically modified) and pas-
saged in the culture. These cells were differentiated from hiPSCs,
which also possibly contained early formed neurons with less AP firing
than primary mouse neurons, higher multipeak calcium spikes than
single peaks as well as slow or mixed calcium waves. The immature
nature of human neural stem cell cultures has been observed and
reported by other laboratories (Patani et al., 2012). The Axol‐ChR2
cells in RGD‐alginate showed excitability upon light stimulation, with
mixed and burst calcium waves recorded. Cell encapsulation is likelyto affect calcium activity and light penetration, further investigation
is required. In Axol‐ChR2 cells, ChR2 expression driven by the CaMKII
promoter (associated to glutamatergic neurons) resulted in higher
levels of calcium activity and calcium spikes even though CaMKII
was a weaker promoter than SYN1. As a pan‐neuronal promoter,
SYN1 has been commonly used in many studies. For example, Weick
and colleagues have utilised the SYN1 promoter (Kugler, Kilic, & Bahr,
2003) to drive ChR2 expression in hESC‐derived neurons with a vari-
ety of neurotransmitter phenotypes. Light stimulation of these cells
expressing ChR2 could reliably drive high AP frequencies (5–30 Hz)
depending on cell maturity. They reported that ChR2 mediated light
stimulation induced post‐synaptic currents in glutamatergic and
GABAergic neurons both in vitro and in vivo (within transplanted tis-
sue) for at least 6 months (Weick et al., 2010). Despite lentiviral trans-
duction, successful ChR2 expression within Axol cells driven by
CaMKII in this study was possibly due in part to increased neural mat-
uration achieved through use of higher passages and longer period of
culture.
The aim to create in vitro models of neural networks that closely
resemble those found in vivo has been a challenge. Several groups
have worked on efficient neural differentiation of hiPSCs but mostly
this has taken place in 2D culture systems (Shi, Kirwan, Smith, Robin-
son, & Livesey, 2012). Only a few studies described the 3D hydrogel
culture of dissociated neural stem/progenitor cells derived from
hPSCs (Alessandri et al., 2016; Sun et al., 2017). We report a novel
strategy to combine the use of RGD‐alginate hydrogel and
optogenetic approach to generate a 3D in vitro model of human
FIGURE 7 Continued.
LEE ET AL. 13neural networks. Our findings demonstrated that hiPSC‐derived
neurons (Axol‐ChR2) exhibit the expression of ChR2‐eYFP and are
responsive to light stimulation (optically excitable) when encapsu-
lated in the RGD‐alginate beads. Moreover, a high number of cal-
cium spikes (both single and multipeak) was observed, driven by
the CaMKII and SYN1 promoter upon light stimulation, indicating
the presence of functional mature neurons. The expression triggered
by CaMKII facilitates identification of glutamatergic excitatory neu-
rons, whereas SYN1 has efficiently labelled GABAergic inhibitoryneurons. The transparent 3D RGD‐alginate systems not only support
survival of Axol‐ChR2 cells but also permit penetration of light for
ChR2‐eYFP activation, as well as allow recording of
neurophysiological activity through the visualisation of calcium
transients concentration changes using calcium imaging. Further
electrophysiology analysis of functional connectivity and electrical
properties of the 3D neural networks in RGD‐alginate beads could
be investigated using multielectrode array recording in the future
(Heikkila et al., 2009).
FIGURE 8 Upon light stimulation, an increased number of calcium
spikes (single peak and multipeak) was observed in Axol‐ChR2 cells
driven by SYN1 and CaMKII promoter, indicating functional activity
achieved in a 3D neural model using RGD‐alginate. The
optogenetically modified cells (Axol‐ChR2‐SYN1 and Axol‐ChR2‐
CaMKII) and unmodified Axol cells were encapsulated in the alginate
bead system (RGD‐ALG), respectively. The cell constructs were
stained with calcium dye and imaged using confocal microscopy
(Zeiss‐LSM 710). Total of 34 active cell aggregates were selected from
the ROIs (N = 3) and stimulated with light before further analysed for
the number of calcium spikes. Significance was tested by two‐way
ANOVA * = p < 0.05; error bars represent standard deviation (± SD)
14 LEE ET AL.5 | CONCLUSIONS
In the current study, we show that hiPSC‐derived neuronal cells are
successfully generated and optogenetically engineered. The expres-
sion of ChR2 is efficiently driven by neuron‐specific promoters
CaMKII and SYN1, indicating the potential to target within the excit-
atory and inhibitory neural populations. The ChR2‐positive neurons
are not only viable but also detectable inside a transparent RGD‐alginate hydrogel using calcium imaging. In conclusion, the cell‐
biomaterial construct created in this study combined with the
optogenetic approach leads to the establishment of a functional 3D
neural network model, which can be used for future drug screening
purposes, non‐invasive repetitive functionality analysis and
neuromodulation, as well as providing new information for neural tis-
sue engineering and stem cell research.
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Figure S1. Comparison of the promoters (synapsin‐1, calcium‐calmod-
ulin kinase II, and elongation factor‐1 alpha) in channelrhodopsin‐2
(ChR2) expression (%) at different viral transduction condition (a) mul-
tiple of infection‐1 and (b) multiple of infection‐2. The quantification
of ChR2 expression was performed using flow cytometry (N = 3). Sig-
nificance was tested by ANOVA; * = p < 0.05; error bars denote stan-
dard error of deviation (± SD).
Figure S2. The human embryonic stem cells (HUES2) expressed plurip-
otent markers at the time of encapsulation. (a) The cells were fixed in
4% paraformaldehyde in PBS for 30 min at room temperature (RT),
washed with PBS, and then stained with OCT‐4, NANOG, ALP, and
SSEA‐4 (R&D system, Minnesota, United States), respectively for
60 min at RT. Cells were resuspended in blocking donkey serum,permeabilised and incubated with intracellular markers at 4°C in the
dark for 30 min. Samples were washed twice carefully in the cold
room before being stained with secondary antibody (Fluorescein iso-
thiocyanate (FITC) ‐conjugated goat anti‐mouse, 1:20 and FITC‐conju-
gated donkey anti‐goat, 1:500, R&D system). The nuclei were
counterstained with DAPI (blue), and the cells were imaged using a
fluorescence microscope (Nikon Eclipse Ti‐E, Japan). Scale bar:
100 μm. (b) For flow cytometry experiments, cells were incubated
with ALP and SSEA‐4 unconjugated antibody (R&D systems) to mark
the expression of cell surface antigens. For intracellular staining with
OCT‐4 ‐ PerCP‐Cy5.5 and NANOG – PerCP‐Cy5.5 (BD Bioscience),
the cells were fixed with 4% paraformaldehyde in PBS for 10 min,
washed twice with PBS, and permeabilised with 0.1% saponin in PBS
prior to incubation with antibodies. All antibody incubations were per-
formed according to the manufacturer's instructions. Isotype controls
were included for each antibody staining, and the emission wave-
length of 488 nm was used. Cell Quest Pro software was used for
both data acquisition and analysis to produce histogram plots and
median peak values. As a control for nonspecific binding for each con-
jugated antibody, we used the same IgG subclass with the same fluo-
rochrome conjugation and for nonconjugated antibody—the same IgG
subclass conjugated to fluorochrome. A total of 10,000 events were
acquired for each analysis. (c) The HUES2 cells expressed neural
marker β‐III Tubulin at Day 14 and Day 21 of neural differentiation.
The cells were imaged at excitation wavelength of 568 nm using a
fluorescence microscope (Nikon Eclipse Ti‐E, Japan).
Figure S3. Classification of calcium events obtained from calcium
imaging. Traces represent typical examples of calcium imaging time
series over 5 min from different region of interests, which were classi-
fied based on the calcium waves: (a) inactive, (b) slow undefined, (c)
slow rise, (d) burst, and (e) mixed.
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